CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About What We Do Programs and Services CADTH Reimbursement Review Alglucosidase

Alglucosidase

Last Updated: October 10, 2006

Result type: Reports

Project Number: SR0080-000

Product Line: Reimbursement Review

Generic Name: Alglucosidase

Brand Name: Myozyme

Manufacturer: Genzyme Canada Inc.

Therapeutic Area: Pompe's disease

Indications: Pompe’s disease

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 14, 2007

Recommendation Type: List with clinical criteria and/or conditions

Alglucosidase

Files